Business of Medicine
Telehealth visits were responsible for the rise in use of services.
The increase in the number of lawsuits raises concerns about how courts and juries might decide long COVID claims when so much about the condition...
With no definitive blood tests or scans for long COVID that could confirm a diagnosis, some say doctors may feel uncomfortable in this role.
One should not underestimate the sweeping scope of this new federal requirement.
“If other states see a positive effect on Tennessee or are exploring ways to alleviate their own shortages, it’s possible [they] might follow suit...
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
Regardless of patients’ socioeconmic status, copays were related to adherence.
MedPAC’s recommendation on Part B add-on pay for costly drugs met strong resistance, but reactions were mixed to a plan to reduce reimbursement...
“If you just treat people based on what the likelihood is, statistically, you’re going to miss a lot of life-threatening conditions.”